https://www.inhibikase.com/investors/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_36dbb71928886c79e446b0ffcae1c0b0/inhibikase/files/theme/images/logo-sm.png /investors Equisolve Investor Relations Suite https://www.inhibikase.com/investors/news-events/press-releases/detail/148/inhibikase-therapeutics-announces-participation-in-upcoming Tue, 27 Oct 26 08:00:00 -0400 https://www.inhibikase.com/investors/news-events/press-releases/detail/148/inhibikase-therapeutics-announces-participation-in-upcoming https://www.inhibikase.com/investors/news-events/press-releases/detail/147/inhibikase-therapeutics-appoints-scott-wasserman-to-board Tue, 20 Oct 26 16:01:00 -0400 https://www.inhibikase.com/investors/news-events/press-releases/detail/147/inhibikase-therapeutics-appoints-scott-wasserman-to-board https://www.inhibikase.com/investors/news-events/press-releases/detail/146/inhibikase-therapeutics-announces-inducement-grants-under Fri, 02 Oct 26 16:01:00 -0400 https://www.inhibikase.com/investors/news-events/press-releases/detail/146/inhibikase-therapeutics-announces-inducement-grants-under https://www.inhibikase.com/investors/news-events/press-releases/detail/145/inhibikase-therapeutics-announces-second-quarter-2026 Tue, 11 Aug 26 16:01:00 -0400 https://www.inhibikase.com/investors/news-events/press-releases/detail/145/inhibikase-therapeutics-announces-second-quarter-2026 https://www.inhibikase.com/investors/news-events/press-releases/detail/144/inhibikase-therapeutics-announces-fda-orphan-drug Thu, 23 Jul 26 08:00:00 -0400 https://www.inhibikase.com/investors/news-events/press-releases/detail/144/inhibikase-therapeutics-announces-fda-orphan-drug https://www.inhibikase.com/investors/news-events/press-releases/detail/143/inhibikase-therapeutics-announces-sale-of-50-million-of Tue, 14 Jul 26 08:00:00 -0400 https://www.inhibikase.com/investors/news-events/press-releases/detail/143/inhibikase-therapeutics-announces-sale-of-50-million-of https://www.inhibikase.com/investors/news-events/press-releases/detail/142/inhibikase-therapeutics-announces-inducement-grants-under Thu, 02 Jul 26 16:01:00 -0400 https://www.inhibikase.com/investors/news-events/press-releases/detail/142/inhibikase-therapeutics-announces-inducement-grants-under https://www.inhibikase.com/investors/news-events/press-releases/detail/141/inhibikase-therapeutics-announces-first-quarter-2026 Tue, 12 May 26 16:01:00 -0400 https://www.inhibikase.com/investors/news-events/press-releases/detail/141/inhibikase-therapeutics-announces-first-quarter-2026 https://www.inhibikase.com/investors/news-events/press-releases/detail/140/inhibikase-therapeutics-announces-enrollment-of-first Tue, 07 Apr 26 08:00:00 -0400 https://www.inhibikase.com/investors/news-events/press-releases/detail/140/inhibikase-therapeutics-announces-enrollment-of-first https://www.inhibikase.com/investors/news-events/press-releases/detail/139/inhibikase-therapeutics-announces-inducement-grants-under Fri, 03 Apr 26 14:01:00 -0400 https://www.inhibikase.com/investors/news-events/press-releases/detail/139/inhibikase-therapeutics-announces-inducement-grants-under